JP2002521391A5 - - Google Patents

Download PDF

Info

Publication number
JP2002521391A5
JP2002521391A5 JP2000561222A JP2000561222A JP2002521391A5 JP 2002521391 A5 JP2002521391 A5 JP 2002521391A5 JP 2000561222 A JP2000561222 A JP 2000561222A JP 2000561222 A JP2000561222 A JP 2000561222A JP 2002521391 A5 JP2002521391 A5 JP 2002521391A5
Authority
JP
Japan
Prior art keywords
antibody
hepatitis
polynucleotide
subject
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000561222A
Other languages
English (en)
Japanese (ja)
Other versions
JP4593783B2 (ja
JP2002521391A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1999/005173 external-priority patent/WO2000005266A1/en
Publication of JP2002521391A publication Critical patent/JP2002521391A/ja
Publication of JP2002521391A5 publication Critical patent/JP2002521391A5/ja
Application granted granted Critical
Publication of JP4593783B2 publication Critical patent/JP4593783B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000561222A 1998-07-21 1999-07-20 抗ｃ型肝炎ウイルス抗体およびその使用 Expired - Fee Related JP4593783B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98113595.7 1998-07-21
EP98113595 1998-07-21
PCT/EP1999/005173 WO2000005266A1 (en) 1998-07-21 1999-07-20 Anti hepatitis c virus antibody and uses thereof

Publications (3)

Publication Number Publication Date
JP2002521391A JP2002521391A (ja) 2002-07-16
JP2002521391A5 true JP2002521391A5 (enExample) 2006-08-03
JP4593783B2 JP4593783B2 (ja) 2010-12-08

Family

ID=8232320

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000561222A Expired - Fee Related JP4593783B2 (ja) 1998-07-21 1999-07-20 抗ｃ型肝炎ウイルス抗体およびその使用

Country Status (7)

Country Link
US (3) US6951646B1 (enExample)
EP (1) EP1097172A1 (enExample)
JP (1) JP4593783B2 (enExample)
CN (2) CN1325517C (enExample)
AU (1) AU5285899A (enExample)
CA (1) CA2339045A1 (enExample)
WO (1) WO2000005266A1 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091324B2 (en) * 1998-11-05 2006-08-15 Board Of Trustees Of Leland Stanford Junior University Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
WO2001058459A1 (fr) * 2000-02-14 2001-08-16 Mitsubishi Pharma Corporation Remedes contre l'hepatite c
IL137522A (en) * 2000-07-26 2007-06-17 Drk Blutspendediendst Baden Wu Human monoclonal antibody against hepatitis c virus e2 glycoprotein
EP1178116A1 (en) * 2000-08-03 2002-02-06 Hybrigenics S.A. Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
GB0021859D0 (en) * 2000-09-06 2000-10-18 Imp College Innovations Ltd Methods
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
ITRM20020049A1 (it) * 2002-01-30 2003-07-30 Biostrands S R L Frammenti fab di anticorpi monoclonali umani diretti contro la glicoproteina e2 di hcv e dotati di potere neutralizzante in vitro.
EP1624785B1 (en) * 2003-01-17 2013-07-17 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
CN103965301A (zh) 2003-04-01 2014-08-06 国家健康医学研究所 针对丙型肝炎病毒e1e2复合体的抗体、hcv颗粒的组合物和药物组合物
GB0309126D0 (en) * 2003-04-17 2003-05-28 Neutec Pharma Plc Clostridium difficile focussed antibodies
US7928193B2 (en) * 2004-07-08 2011-04-19 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replication
PT1949913E (pt) * 2005-10-07 2010-08-24 Proyecto Biomedicina Cima Sl Associação imunoestimuladora para a profilaxia e o tratamento da hepatite c
SI2066351T1 (sl) 2006-10-02 2016-02-29 E.R. Squibb & Sons, L.L.C. Humana protitelesa, ki vežejo cxcr4 in njihova uporaba
SG177168A1 (en) 2006-12-01 2012-01-30 Medarex Inc Human antibodies that bind cd22 and uses thereof
CL2007003622A1 (es) 2006-12-13 2009-08-07 Medarex Inc Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
US20100150950A1 (en) 2006-12-14 2010-06-17 Medarex, Inc. Human antibodies that bind cd70 and uses thereof
RS53258B (sr) * 2007-02-21 2014-08-29 University Of Massachusetts Humana antitela protiv virusa hepatitisa c (hcv) i njihove upotrebe
ITTO20080204A1 (it) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
ITTO20080398A1 (it) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
AR072999A1 (es) 2008-08-11 2010-10-06 Medarex Inc Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
CA2745439C (en) 2008-12-03 2019-10-15 Genmab A/S Antibody variants having modifications in the constant region
US20110033389A1 (en) * 2009-04-29 2011-02-10 Zhifeng Chen Modified antibodies for passive immunotherapy
CN102596996B (zh) * 2009-10-30 2014-06-18 东丽株式会社 对丙型肝炎病毒(hcv)具有感染抑制活性的抗体及其用途
CA2800734A1 (en) 2010-05-25 2011-12-01 Universite De Strasbourg Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
AR091649A1 (es) 2012-07-02 2015-02-18 Bristol Myers Squibb Co Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
CN103308697B (zh) * 2013-06-09 2014-11-26 卫生部北京医院 检测抗丙型肝炎病毒编码的非结构蛋白ns3和ns5的天然双特异性抗体的试剂盒
CN103472233A (zh) * 2013-06-21 2013-12-25 温州大学 丙型肝炎检测试剂盒及其应用
CA2918989C (en) 2013-08-09 2021-11-02 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
CN104974246A (zh) * 2014-04-01 2015-10-14 中国科学院上海巴斯德研究所 一种中和丙型肝炎病毒的全人单克隆抗体及其用途
GB201415714D0 (en) * 2014-09-05 2014-10-22 Medical Res Council Antibodies and antigen binding fragments thereof
CN105254756B (zh) * 2015-11-27 2018-09-07 武汉大学 一种针对丙型肝炎病毒包膜蛋白e2的单克隆抗体及应用
CN107286238B (zh) * 2017-08-07 2019-11-26 广州泰诺迪生物科技有限公司 抗hcv广谱中和抗体的制备、检测以及应用
US12247065B2 (en) 2018-06-22 2025-03-11 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
TWI754157B (zh) 2018-07-25 2022-02-01 大陸商信達生物製藥（蘇州）有限公司 抗ｔｉｇｉｔ抗體及其用途
SI3898668T1 (sl) * 2018-12-19 2024-02-29 Humabs Biomed Sa Protitelesa, ki nevtralizirajo virus hepatitisa B in njihove uporabe
PT4285929T (pt) 2018-12-20 2026-01-02 Humabs Biomed Sa Terapêutica de combinação contra o vhb
CN109762067B (zh) 2019-01-17 2020-02-28 北京天广实生物技术股份有限公司 结合人Claudin 18.2的抗体及其用途
US10570210B1 (en) 2019-03-04 2020-02-25 Beijing Mabworks Biotech Co.Ltd Antibodies binding CD40 and uses thereof
CN119708230A (zh) 2020-02-27 2025-03-28 正大天晴药业集团股份有限公司 结合il4r的抗体及其用途
CN121914272A (zh) 2020-05-12 2026-04-24 正大天晴药业集团股份有限公司 St2抗原结合蛋白
JP2024500093A (ja) * 2020-12-10 2024-01-04 ウーシー バイオロジクス アイルランド リミテッド Ｐ－カドヘリンに対する抗体及びその使用
CN118159286A (zh) 2021-11-25 2024-06-07 正大天晴药业集团股份有限公司 抗Siglec-15抗体及其应用
AU2022446336A1 (en) 2022-03-18 2024-09-19 Beijing Mabworks Biotech Co., Ltd B7-h3-binding antibody and use thereof
CN118684767B (zh) * 2024-06-27 2025-02-18 山东省大健康精准医疗产业技术研究院 一种丙肝核心抗原单链抗体及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE520499C (de) 1929-09-14 1931-03-11 Heinrich Elsner Vorrichtung zum Biegen von Pappe, Fiber u. dgl.
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
EP1845108A3 (en) 1994-07-29 2007-10-24 Innogenetics N.V. Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
US6747136B2 (en) * 1996-04-19 2004-06-08 Karolinska Innovations Ab Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
WO2000026418A1 (en) 1998-11-05 2000-05-11 The Board Of Trustees Of Leland Stanford Junior University Human pan-hcv human monoclonal antibodies
AU2001292667A1 (en) 2000-09-13 2002-03-26 Hawaii Biotechnology Group, Inc. Immunogenic composition of hepatitis c and methods of use thereof

Similar Documents

Publication Publication Date Title
CA2406240C (en) Hcv anti-core monoclonal antibodies
JP2020516300A5 (enExample)
CN113549148A (zh) Hcv核心脂质结合结构域单克隆抗体
JP2022169504A5 (enExample)
HRP20140316T1 (hr) Humana antitijela protiv virusa hepatitisa c (hcv) i njihova uporaba
WO2000005266A1 (en) Anti hepatitis c virus antibody and uses thereof
JP2004512824A5 (enExample)
CN118702814B (zh) 一种抗ngf单克隆抗体及其应用
JP2008533986A5 (enExample)
JP2017536821A5 (enExample)
JP2008515388A5 (enExample)
CN117683123A (zh) 抗狂犬病毒人源化抗体和抗体组合及其用途
KR102339334B1 (ko) 인간 메타뉴모바이러스(hMPV)의 항원 M의 특이적 단클론 항체 및 진단 방법에 있어서의 그 용도
KR20220012297A (ko) 항-b형 간염 바이러스 항체 및 이의 용도
JP2025542128A (ja) メタニューモウイルス融合（ｆ）タンパク質に対する抗体及びその使用
CN118085082A (zh) 抗猫TNF-α单克隆抗体及其应用
KR102601835B1 (ko) 말 인플루엔자 바이러스 h3n8형에 특이적인 단일클론항체 및 이를 이용한 말인플루엔자 바이러스 검출용 조성물
WO2019207552A1 (en) Multianalyte immunoassay for zika virus and uses thereof
JPH08510635A (ja) Ｂ型肝炎エスケープミュータント特異的結合分子
TWI741216B (zh) 專一性抑制或減緩ｐｔｘ３與ｐｔｘ３受體結合之單株抗體或其抗原結合片段及其用途
CN107286237B (zh) 一种抗丙型肝炎病毒抗体的获取以及应用
KR102007161B1 (ko) 메르스 코로나 바이러스 스파이크 s1 단백질에 특이적으로 결합하는 단클론 항체
CN118930642B (zh) 一种针对乙型脑炎病毒和寨卡病毒的人源单克隆抗体及其应用
KR102798975B1 (ko) 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도
KR102798983B1 (ko) 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도